Prot# V00400 SB 201: A Randomised, Controlled, Multidose, Multicentre, Adaptive Phase II/III Study in Infants with Proliferating Infantile hemangiomas Requiring Systemic Therapy to Compare Four Regimens of Propranolol (1 or 3 mg/kg/day for 3 or 6 months)

Project: Research project

Project Details

Effective start/end date3/29/103/29/14


  • Ann & Robert H. Lurie Children's Hospital of Chicago (V00400 SB 201)
  • Pierre Fabre Laboratories (V00400 SB 201)